OUR BLOG
Latest Updates & News
At vero eos et accusamus iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos at dolores molestias excepturi sint occaecati cupiditate.
The Importance of Medical Writing for Infectious Disease and Vaccine Programs
See how P95 can support with medical writing for vaccine programs or infectious disease research from regulatory documents to protocols
P95 Partners in South Africa’s Historic Cholera Vaccine Clinical Trial (OcV-S)
P95 is proud to serve as the selected CRO for the cholera vaccine clinical trial of OCV-S, South Africa’s first fully homegrown vaccine
P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence
P95 and Julius Clinical merge forming a 500+ person global CRO spanning 25+ countries with operations in North America, Europe, Africa, Latin America, and Asia-Pacific
qualitative burden of disease study: patients with ied aged ≥ 60 years in the United States
Background Invasive Escherichia coli disease (IED) comprises a diverse range of severe infections caused by E. coli,...
Latin America Rising Role In Global Clinical Research: Opportunities Ahead
Discover how Latin America Rising Role In Global Clinical Research with Rodrigo de Antonio joins and Tom Verstraeten
Conducting Infectious Disease Trials in Low-Income Countries
Discover how conducting infectious disease trials in low-income countries advances global health and improves treatment access.
Systematic Literature Review: Burden of hMPV in Older and High-Risk Adults in Developed Countries
Introduction Human metapneumovirus (hMPV) causes respiratory infections in individuals of all age groups. While the...
Running Vaccine Trials in Africa: What You Need to Know
Learn about about what it truly takes to run vaccine trials in Africa today in this podcast episode
How to Design Phase I Vaccine Studies in Europe Webinar
The How to Design Phase I Vaccine Studies in Europe Webinar is a focused session for sponsors and biotech leaders...
Origins, Growth & Evidence Strategy in Infectious Disease Research
Contagious Thinking Podcast Episode One: Origins, Growth & Evidence Strategy in Infectious Disease Research with P95 CEO Thomas
Expanding with Purpose: P95 Opens New Offices in Ghana and Kenya to Strengthen Vaccine Research Across Africa
In April 2025, P95 proudly opened two new offices on the African continent, in Kenya and Ghana, reinforcing regional impact and collaboration
Pharmacovigilance support in global clinical trials: insights from the CPIVC webinar
P95 shares pharmacovigilance support in global clinical trials through key regulatory insights presented at the CPIVC webinar
Advancing Vaccine Research at World Vaccine Congress Washington 2025
As World Vaccine Congress Washington 2025 comes to a close, we reflect on an impactful three days of collaboration,...
P95 and LatinaBA enter a strategic partnership to propel vaccine research in Latin America
P95 and LatinaBA are pleased to announce their strategic partnership, aimed at propelling vaccine and infectious disease research in Latin America.
COVID-19 vaccine effectiveness study against JN.1 variant using id.DRIVE platform
Background Prior studies have reported lower effectiveness of XBB.1.5-adapted vaccines against hospitalization related...
Protocol development: Observational study EAGLE
Abstract Background: Immunocompromised individuals are known to respond inadequately to SARS-CoV-2 vaccines, placing...
Qualitative study on COVID-19 avoidance behavior after lockdown
Abstract Background: This exploratory qualitative study involved semi-structured interviews with adults and caregivers...
P95 At Vaccine World Asia Congress
P95 successfully exhibited at the Vaccine World Asia Congress 2024, held on 6-7 November in Bangkok, Thailand. The...
P95 At World Vaccine Congress Europe 2024
This October, the P95 team attended and exhibited at Europe's largest vaccine event, the World Vaccine Congress Europe...
P95 Webinar Explores Insights to Conducting Clinical Trials in Africa
Join P95 for its webinar on Insights to conducting clinical trials in Africa, on 5 November.